Enhancement of ATP production ameliorates motor and cognitive impairments in a mouse model of MPTP−induced Parkinson's disease
暂无分享,去创建一个
K. Fukunaga | F. Han | Y. Yabuki | Kazuya Matsuo | Chen Zhang | Hidaka Haga
[1] C. Chu. Multiple pathways for mitophagy: A neurodegenerative conundrum for Parkinson’s disease , 2019, Neuroscience Letters.
[2] David S. Park,et al. Comparative analysis of Parkinson's disease–associated genes in mice reveals altered survival and bioenergetics of Parkin-deficient dopamine neurons , 2018, The Journal of Biological Chemistry.
[3] S. Gygi,et al. Dynamics of PARKIN-Dependent Mitochondrial Ubiquitylation in Induced Neurons and Model Systems Revealed by Digital Snapshot Proteomics. , 2018, Molecular cell.
[4] G. Deuschl,et al. Analysis of blood-based gene expression in idiopathic Parkinson disease , 2017, Neurology.
[5] R. Takahashi,et al. ATP Maintenance via Two Types of ATP Regulators Mitigates Pathological Phenotypes in Mouse Models of Parkinson's Disease , 2017, EBioMedicine.
[6] G. Lazzari,et al. Pyruvate antioxidant roles in human fibroblasts and embryonic stem cells , 2017, Molecular and Cellular Biochemistry.
[7] K. Fukunaga,et al. Dehydroepiandrosterone administration improves memory deficits following transient brain ischemia through sigma-1 receptor stimulation , 2015, Brain Research.
[8] N. Hattori,et al. Utility of the Japanese version of the 9-item Wearing-off Questionnaire , 2015, Clinical Neurology and Neurosurgery.
[9] D. Miljković,et al. Short term exposure to ethyl pyruvate has long term anti-inflammatory effects on microglial cells. , 2015, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[10] F. Berardi,et al. Live imaging reveals a new role for the sigma-1 (σ 1) receptor in allowing microglia to leave brain injuries , 2015, Neuroscience Letters.
[11] Liang Tong,et al. Structures of human phosphofructokinase-1 and atomic basis of cancer-associated mutations , 2015, Nature.
[12] R. Youle,et al. The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease , 2015, Neuron.
[13] K. Fukunaga,et al. Methyl pyruvate rescues mitochondrial damage caused by SIGMAR1 mutation related to amyotrophic lateral sclerosis. , 2014, Biochimica et biophysica acta.
[14] Y. Ohizumi,et al. Nobiletin treatment improves motor and cognitive deficits seen in MPTP-induced Parkinson model mice , 2014, Neuroscience.
[15] A. Albanese,et al. Early DEtection of wEaring off in Parkinson disease: the DEEP study. , 2014, Parkinsonism & related disorders.
[16] Ja-Kyeong Lee,et al. Ethyl pyruvate inhibits HMGB1 phosphorylation and secretion in activated microglia and in the postischemic brain , 2014, Neuroscience Letters.
[17] K. Fukunaga,et al. Oral administration of glutathione improves memory deficits following transient brain ischemia by reducing brain oxidative stress , 2013, Neuroscience.
[18] Marc Flajolet,et al. Advances in the pharmacological treatment of Parkinson's disease: targeting neurotransmitter systems , 2013, Trends in Neurosciences.
[19] R. Bhattacharya,et al. Neuroprotective effects of alpha-ketoglutarate and ethyl pyruvate against motor dysfunction and oxidative changes caused by repeated 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine exposure in mice , 2013, Human & experimental toxicology.
[20] A. Cumaoğlu,et al. Age- and diabetes-induced regulation of oxidative protein modification in rat brain and peripheral tissues: Consequences of treatment with antioxidant pyridoindole , 2013, Experimental Gerontology.
[21] T. Zeng,et al. Elevation of 4-hydroxynonenal and malondialdehyde modified protein levels in cerebral cortex with cognitive dysfunction in rats exposed to 1-bromopropane. , 2013, Toxicology.
[22] K. Fukunaga,et al. Stimulation of σ1-receptor restores abnormal mitochondrial Ca²⁺ mobilization and ATP production following cardiac hypertrophy. , 2013, Biochimica et biophysica acta.
[23] Li-wen Chang,et al. Sodium Pyruvate Reduced Hypoxic-Ischemic Injury to Neonatal Rat Brain , 2012, Pediatric Research.
[24] M. Zarrindast,et al. Activation of dopamine D1 receptors in the medial septum improves scopolamine-induced amnesia in the dorsal hippocampus , 2012, Behavioural Brain Research.
[25] K. Fukunaga,et al. Reduced calcium/calmodulin‐dependent protein kinase II activity in the hippocampus is associated with impaired cognitive function in MPTP‐treated mice , 2012, Journal of neurochemistry.
[26] M. Cammarota,et al. D1/D5 dopamine receptors modulate spatial memory formation , 2012, Neurobiology of Learning and Memory.
[27] Y. Pak,et al. Ethyl Pyruvate Rescues Nigrostriatal Dopaminergic Neurons by Regulating Glial Activation in a Mouse Model of Parkinson’s Disease , 2011, The Journal of Immunology.
[28] R. Roesler,et al. Modulatory influence of dopamine receptors on consolidation of object recognition memory , 2011, Neurobiology of Learning and Memory.
[29] H. Toresson,et al. The sigma-1 receptor enhances brain plasticity and functional recovery after experimental stroke. , 2011, Brain : a journal of neurology.
[30] M. Watkins,et al. Postischemic treatment with ethyl pyruvate prevents adenosine triphosphate depletion, ameliorates inflammation, and decreases thrombosis in a murine model of hind-limb ischemia and reperfusion. , 2011, The Journal of trauma.
[31] R. Sutton,et al. Beneficial effects of sodium or ethyl pyruvate after traumatic brain injury in the rat , 2010, Experimental Neurology.
[32] José María Delgado-García,et al. Associative Learning and CA3–CA1 Synaptic Plasticity Are Impaired in D1R Null, Drd1a−/− Mice and in Hippocampal siRNA Silenced Drd1a Mice , 2010, The Journal of Neuroscience.
[33] M. Fink,et al. The biochemical basis for the anti-inflammatory and cytoprotective actions of ethyl pyruvate and related compounds. , 2010, Biochemical pharmacology.
[34] Jun Chen,et al. Ethyl pyruvate protects against hypoxic-ischemic brain injury via anti-cell death and anti-inflammatory mechanisms , 2010, Neurobiology of Disease.
[35] M. Tarnopolsky,et al. The effect of aging on human skeletal muscle mitochondrial and intramyocellular lipid ultrastructure. , 2010, The journals of gerontology. Series A, Biological sciences and medical sciences.
[36] Chi V Dang,et al. Rethinking the Warburg effect with Myc micromanaging glutamine metabolism. , 2010, Cancer research.
[37] A. Trifunovic,et al. The mtDNA mutator mouse: Dissecting mitochondrial involvement in aging , 2009, Aging.
[38] T. Seike,et al. Hydrogen in Drinking Water Reduces Dopaminergic Neuronal Loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Mouse Model of Parkinson's Disease , 2009, PloS one.
[39] A. Sepulveda,et al. Ethyl pyruvate decreases HMGB1 release and ameliorates murine colitis , 2009, Journal of leukocyte biology.
[40] L. Cantley,et al. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.
[41] J. Jeon,et al. Ethyl pyruvate has an anti-inflammatory effect by inhibiting ROS-dependent STAT signaling in activated microglia. , 2008, Free radical biology & medicine.
[42] Eduardo D. Martín,et al. D1 but not D5 dopamine receptors are critical for LTP, spatial learning, and LTP-Induced arc and zif268 expression in the hippocampus. , 2008, Cerebral cortex.
[43] Teruo Hayashi,et al. Sigma-1 Receptor Chaperones at the ER- Mitochondrion Interface Regulate Ca2+ Signaling and Cell Survival , 2007, Cell.
[44] T. James,et al. Exogenous Ethyl Pyruvate versus Pyruvate during Metabolic Recovery after Oxidative Stress in Neonatal Rat Cerebrocortical Slices , 2007, Anesthesiology.
[45] N. Fuku,et al. Therapeutic potential of pyruvate therapy for mitochondrial diseases. , 2007, Mitochondrion.
[46] Ann Saada,et al. Biochemical assays for mitochondrial activity: assays of TCA cycle enzymes and PDHc. , 2007, Methods in cell biology.
[47] C. Mannella,et al. Structural and functional features and significance of the physical linkage between ER and mitochondria , 2006, The Journal of cell biology.
[48] N. Lemon,et al. Dopamine D1/D5 Receptors Gate the Acquisition of Novel Information through Hippocampal Long-Term Potentiation and Long-Term Depression , 2006, The Journal of Neuroscience.
[49] T. Dawson,et al. Diagnosis and treatment of Parkinson disease: molecules to medicine. , 2006, The Journal of clinical investigation.
[50] K. Nair,et al. Decline in skeletal muscle mitochondrial function with aging in humans. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[51] M. Berry,et al. Ethyl pyruvate preserves cardiac function and attenuates oxidative injury after prolonged myocardial ischemia. , 2004, The Journal of thoracic and cardiovascular surgery.
[52] R. G. Kemp,et al. Allosteric regulatory properties of muscle phosphofructokinase , 2004, Molecular and Cellular Biochemistry.
[53] K. Fukunaga,et al. The neuroprotective effect of a novel calmodulin antagonist, 3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1h-indazole dihydrochloride 3.5 hydrate, in transient forebrain ischemia , 2003, Neuroscience.
[54] W. Dauer,et al. Parkinson's Disease Mechanisms and Models , 2003, Neuron.
[55] K. Soliman,et al. Pyruvic acid cytoprotection against 1-methyl-4-phenylpyridinium, 6-hydroxydopamine and hydrogen peroxide toxicities in vitro , 2003, Neuroscience Letters.
[56] K. Tracey,et al. Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[57] J. Koh,et al. Protection by Pyruvate against Transient Forebrain Ischemia in Rats , 2001, The Journal of Neuroscience.
[58] P. Esselman,et al. Oxidative capacity and ageing in human muscle , 2000, The Journal of physiology.
[59] K. Nair,et al. Effects of Aging on Mitochondrial DNA Copy Number and Cytochromec Oxidase Gene Expression in Rat Skeletal Muscle, Liver, and Heart* , 2000, The Journal of Biological Chemistry.
[60] W. Tatton,et al. Etiology and pathogenesis of Parkinson's disease. , 1999, Annual review of neuroscience.
[61] G. Rutter,et al. Integrating cytosolic calcium signals into mitochondrial metabolic responses , 1998, The EMBO journal.
[62] K. Matsuno,et al. Activation of σ 1 receptor subtype leads to neuroprotection in the rat primary neuronal cultures , 1998, Neurochemistry International.
[63] R. Depue,et al. Opposing roles for dopamine and serotonin in the modulation of human spatial working memory functions. , 1998, Cerebral cortex.
[64] George Paxinos,et al. The Mouse Brain in Stereotaxic Coordinates , 2001 .
[65] M. Beal,et al. Coenzyme Q10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects , 1997, Annals of neurology.
[66] R. Quirion,et al. Local modulation of hippocampal acetylcholine release by dopamine D1 receptors: a combined receptor autoradiography and in vivo dialysis study , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[67] P. Goldman-Rakic,et al. Dopamine D2 receptor mechanisms contribute to age-related cognitive decline: the effects of quinpirole on memory and motor performance in monkeys , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[68] H. Eichenbaum,et al. The hippocampus--what does it do? , 1992, Behavioral and neural biology.
[69] F. Di Virgilio,et al. Extracellular ATP causes lysis of mouse thymocytes and activates a plasma membrane ion channel. , 1991, The Biochemical journal.
[70] F. Di Virgilio,et al. Responses of mouse lymphocytes to extracellular ATP. II. Extracellular ATP causes cell type-dependent lysis and DNA fragmentation. , 1990, Journal of immunology.
[71] M. Sitkovsky,et al. Ecto-ATPase activity in cytolytic T-lymphocytes. Protection from the cytolytic effects of extracellular ATP. , 1990, The Journal of biological chemistry.
[72] A. H. V. Schapira,et al. MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE , 1989, The Lancet.
[73] W. Schaper,et al. Biochemical mechanism of infarct size reduction by pyruvate. , 1981, Cardiovascular research.
[74] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[75] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.
[76] O. Hornykiewicz. Dopamine (3-hydroxytyramine) and brain function. , 1966, Pharmacological reviews.
[77] R. W. Korff. PYRUVATE-C14, PURITY AND STABILITY. , 1964 .
[78] Webb Jl,et al. Metabolic studies on heart mitochondria. II. The inhibitory action of parapyruvate on the tricarboxylic acid cycle. , 1956 .
[79] C. M. Montgomery,et al. Metabolic studies on heart mitochondria. II. The inhibitory action of parapyruvate on the tricarboxylic acid cycle. , 1956, The Journal of biological chemistry.